PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
Sign in to add to a watchlist →
lobbying_client · US · canonical: pharmaceutical research manufacturers america phrma · 2 aliases · 6 outbound · 4 inbound
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-18 · lobbied by Rick Desimone · lda_lobbyist_client
- 2026-05-18 · lobbied by Matthew Mcginley · lda_lobbyist_client
- 2026-01-01 · lobbied on To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. (hr 1492) · lobbying_bill_mention
- 2026-01-01 · lobbied on PBM Reform Act of 2025 (h.r.4317) · lobbying_bill_mention
- 2026-01-01 · lobbied on EPIC Act of 2025 (s.832) · lobbying_bill_mention
- 2026-01-01 · lobbied on PBM Price Transparency and Accountability Act (s.3345) · lobbying_bill_mention
- 2026-01-01 · lobbied on Consolidated Appropriations Act, 2026 (h.r.7148) · lobbying_bill_mention
- 2026-01-01 · lobbied for by ADVANCED POLICY CONSULTING, LLC $40,000 · lda_filing
- 2026-01-01 · lobbied on DRUG Act (hr 2214) · lobbying_bill_mention
- 2026-01-01 · lobbied for by DESIMONE CONSULTING, LLC $30,000 · lda_filing
Lobbying disclosures — as CLIENT (2)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-14 | 1st Quarter - Report | 2026 | first_quarter | 400931695 | $30,000 | — |
| 2026-04-14 | 1st Quarter - Report | 2026 | first_quarter | 401103524 | $40,000 | — |
Aliases (2)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 199376 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | US | gold | backfill_0029 | |
| lda_client | 196261 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | US | gold | backfill_0029 |
Outbound edges (6)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 1492 — To amend title XI of the Social Security Act to equalize the negotiation period between sm | — | HR 1492 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 2214 — DRUG Act | — | HR 2214 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 832 — EPIC Act of 2025 | — | S.832 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 4317 — PBM Reform Act of 2025 | — | H.R.4317 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 7148 — Consolidated Appropriations Act, 2026 | — | H.R.7148 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 3345 — PBM Price Transparency and Accountability Act | — | S.3345 | lobbying_bill_mention |
Inbound edges (4)
| date | from | type | amount | source |
|---|---|---|---|---|
| — | Matthew Mcginley | lobbied_for | — | lda_lobbyist_client |
| — | Rick Desimone | lobbied_for | — | lda_lobbyist_client |
| 2026-01-01 | ADVANCED POLICY CONSULTING, LLC | lobbies_for | $40,000 | lda_filing |
| 2026-01-01 | DESIMONE CONSULTING, LLC | lobbies_for | $30,000 | lda_filing |